-transparent.png){kind=logo}
To summarize the results: Bilirubin removal by hemoperfusion was successfully performed for the first time on a premature infant. The hemoperfusion caused no adverse effects on the clinical state of the infant. The bilirubin removed in 90 min--13 mg--indicates the existence of a large extravascular pool. Hemoperfusion is suggested for bilirubin removal from newborn babies, reducing the need for blood exchange with bank blood.
Related Publications
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
September 1986,
The International journal of artificial organs,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
July 1981,
The International journal of artificial organs,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
May 1981,
The International journal of artificial organs,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
September 1986,
The International journal of artificial organs,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
September 1989,
Clinica chimica acta; international journal of clinical chemistry,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
October 1977,
The American journal of gastroenterology,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
January 1992,
Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
September 1975,
Lancet (London, England),
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
March 1968,
Minerva pediatrica,
J M Brandes, and
L Mor, and
S Sideman, and
M Zeltzer, and
P Sujov, and
S Blazer
July 2005,
The International journal of artificial organs,
